Alligator Bioscience AB (FRA:7AL0) E10: €-0.84 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Alligator Bioscience AB E10?

Alligator Bioscience AB FRA:7AL0 E10 is €-0.84 as of Jun. 2026. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alligator Bioscience AB's adjusted earnings per share data for the three months ended in Jun. 2026 was €-0.004. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.84 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-07), Alligator Bioscience AB's current stock price is €0.0001. Alligator Bioscience AB's E10 for the quarter that ended in Jun. 2026 was €-0.84. Alligator Bioscience AB's Shiller PE Ratio of today is .


Alligator Bioscience AB  (FRA:7AL0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alligator Bioscience AB E10 Related Terms


Alligator Bioscience AB E10 Historical Data

* Premium members only.

The historical data trend for Alligator Bioscience AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alligator Bioscience AB E10 Chart

Alligator Bioscience AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -93.35

Alligator Bioscience AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -145.34 -142.86 -93.35 0.00 -0.84

FRA:7AL0 vs VRTX, REGN, MRNA: E10 Comparison

For the Biotechnology subindustry, Alligator Bioscience AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alligator Bioscience AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's Shiller PE Ratio falls into.



Alligator Bioscience AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alligator Bioscience AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.004/134.6100*134.6100
=-0.004

Current CPI (Jun. 2026) = 134.6100.

Alligator Bioscience AB Quarterly Data

per share eps CPI Adj_EPS
201609 -0.202 101.138 -0.269
201612 -0.475 102.022 -0.627
201703 -0.421 102.022 -0.555
201706 -0.656 102.752 -0.859
201709 -0.561 103.279 -0.731
201712 0.270 103.793 0.350
201803 -0.864 103.962 -1.119
201806 -0.767 104.875 -0.984
201809 -0.798 105.679 -1.016
201812 -0.622 105.912 -0.791
201903 -0.878 105.886 -1.116
201906 -0.965 106.742 -1.217
201909 -1.099 107.214 -1.380
201912 -1.178 107.766 -1.471
202003 -0.855 106.563 -1.080
202006 -0.725 107.498 -0.908
202009 -0.639 107.635 -0.799
202012 -1.027 108.296 -1.277
202103 -0.699 108.360 -0.868
202106 -0.719 108.928 -0.889
202109 -0.749 110.338 -0.914
202112 -0.527 112.486 -0.631
202203 -0.321 114.825 -0.376
202206 -0.553 118.384 -0.629
202209 -0.595 122.296 -0.655
202212 -0.610 126.365 -0.650
202303 -0.697 127.042 -0.739
202306 -0.455 129.407 -0.473
202309 -0.189 130.224 -0.195
202312 -0.275 131.912 -0.281
202403 -0.235 132.205 -0.239
202406 -1,941.748 132.716 -1,969.459
202409 -2.553 132.304 -2.597
202412 -0.105 132.987 -0.106
202503 -0.033 132.825 -0.033
202506 -0.005 133.699 -0.005
202509 -0.010 133.480 -0.010
202512 -0.041 133.390 -0.041
202603 0.000 133.560 0.000
202606 -0.004 134.610 -0.004

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.84 mean?
Alligator Bioscience AB (FRA:7AL0) has a E10 of €-0.84 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alligator Bioscience AB and its competitors.
Is Alligator Bioscience AB's E10 too high?
Alligator Bioscience AB's current E10 is €-0.84.
How does Alligator Bioscience AB's E10 compare to VRTX and REGN?
Alligator Bioscience AB's E10 of €-0.84 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alligator Bioscience AB and its competitors. Alligator Bioscience AB's current E10 is €-0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alligator Bioscience AB stock overvalued right now?
Alligator Bioscience AB (FRA:7AL0) has a current E10 of €-0.84. The current E10 is €-0.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Alligator Bioscience AB (FRA:7AL0), the current E10 is €-0.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alligator Bioscience AB Business Description

Other Exchanges ATORX:Sweden0RK9:UK
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. The company's main drug candidate, mitazalimab, is currently under development as a therapy for metastatic pancreatic cancer patients. Its development pipeline also comprises: ATOR-4066, a bispecific antibody targeting CD40, as well as CEACAM5 (carcinoembryonic antigen 5), a protein found in certain tumors; and certain externally developed programs like HLX22 and ALG.APV-527. Geographically, the company generates maximum revenue from Belgium (mainly through out-licensing), and also has its presence in Sweden and Finland.